Ribosomal Incorporation of Fluorosulfonyloxy-<scp><i>l</i></scp>-Phenylalanine into Macrocyclic Peptides for De Novo Target-Specific Covalent Binders
Yawen Yang(Shandong University), Yizhen Yin(Shandong University), Wenfeng Cai(Shandong University), Junjie Wu(Beihang University), Xi‐Yang Cui(Chinese Academy of Medical Sciences & Peking Union Medical College), Pei Liu(Southwest University), Zhibo Liu(Beijing National Laboratory for Molecular Sciences), Xiao‐Wei Fan(Beijing Tsinghua Chang Gung Hospital), Chuanjie Lu(Peking University), Youming Zhang(Shandong University), Jie Cheng(North China Electric Power University)
Cited by 5
Related Papers
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
A corrosion-resistant RuMoNi catalyst for efficient and long-lasting seawater oxidation and anion exchange membrane electrolyzer
|Nature Communications|2023|483
Chinese Baijiu: The Perfect Works of Microorganisms
|Frontiers in Microbiology|2022|211
Covalent targeted radioligands potentiate radionuclide therapy
|Nature|2024|165